{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:17:57Z","timestamp":1788365877556,"version":"build-2803163510"},"reference-count":28,"publisher":"AACN Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.4037\/aacnacc2026745","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:28:46Z","timestamp":1788362926000},"page":"265-271","source":"Crossref","is-referenced-by-count":0,"title":["Finding the Right Dose: Optimizing Drug Therapy in Critically Ill Patients With Obesity"],"prefix":"10.4037","volume":"37","author":[{"given":"Lauren","family":"Finch","sequence":"first","affiliation":[{"name":"Lauren Finch is Postgraduate Year 2 Critical Care Pharmacy Resident, Department of Pharmacy Services, Tampa General Hospital, PO Box 1289, Tampa, FL 33601-1289 (laurenfinch1297@gmail.com)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyne","family":"DaSilva","sequence":"additional","affiliation":[{"name":"Carolyne DaSilva is Clinical Pharmacist, Vascular Intensive Care Unit, Department of Pharmacy Services, Tampa General Hospital, Tampa, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uyen","family":"Diep","sequence":"additional","affiliation":[{"name":"Uyen Diep is Clinical Pharmacist, Medical Intensive Care Unit, Department of Pharmacy Services, Tampa General Hospital, Tampa, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2471","reference":[{"key":"2026090211284261800_b1-0370265","unstructured":"Obesity and severe obesity prevalence in adults: United States, August 2021\u2013August 2023. Centers for Disease Control and Prevention. September\u20082024. Accessed November 13, 2025. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db508.htm"},{"issue":"6","key":"2026090211284261800_b2-0370265","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00134-019-05594-1","article-title":"Obesity in the critically ill: a narrative review","volume":"45","author":"Schetz","year":"2019","journal-title":"Intensive Care Med"},{"issue":"6","key":"2026090211284261800_b3-0370265","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.chest.2021.08.001","article-title":"Impact of obesity in critical illness","volume":"160","author":"Anderson","year":"2021","journal-title":"Chest"},{"issue":"2","key":"2026090211284261800_b4-0370265","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40262-023-01213-x","article-title":"Pharmacokinetic alterations associated with critical illness","volume":"62","author":"Morales Castro","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"2026090211284261800_b5-0370265","doi-asserted-by":"publisher","first-page":"115281","DOI":"10.1016\/j.biopha.2023.115281","article-title":"Pharmacokinetics of obese adults: not only an increase in weight","volume":"166","author":"Gouju","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"suppl 2","key":"2026090211284261800_b6-0370265","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1002\/jcph.2361","article-title":"The importance of assessing drug pharmacokinetics and pharmacodynamics in the obese population during drug development","volume":"63","author":"Moore","year":"2023","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"2026090211284261800_b7-0370265","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13054-021-03495-8","article-title":"Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis","volume":"25","author":"Erstad","year":"2021","journal-title":"Crit Care"},{"issue":"1","key":"2026090211284261800_b8-0370265","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4037\/ajcc2016667","article-title":"Norepinephrine dosing in obese and nonobese patients with septic shock","volume":"25","author":"Radosevich","year":"2016","journal-title":"Am J Crit Care"},{"issue":"1","key":"2026090211284261800_b9-0370265","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13054-020-03040-z","article-title":"Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium","volume":"24","author":"Erstad","year":"2020","journal-title":"Crit Care"},{"issue":"5","key":"2026090211284261800_b10-0370265","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.bja.2018.01.040","article-title":"Dexmedetomidine metabolic clearance is not affected by fat mass in obese patients","volume":"120","author":"Rolle","year":"2018","journal-title":"Br J Anaesth"},{"issue":"10","key":"2026090211284261800_b11-0370265","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s40262-014-0166-x","article-title":"Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteers","volume":"53","author":"Brill","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"2026090211284261800_b12-0370265","unstructured":"Sud\u2008P, Lee\u2008DC. Sedative-hypnotics. In: Nelson\u2008LS, Howland\u2008MA, Lewin\u2008NA, Smith\u2008SW, Goldfrank\u2008LR, Hoffman\u2008RS, eds. Goldfrank\u2019s Toxicologic Emergencies. 11th ed. McGraw-Hill Education; 2019: chapter 72. Accessed November 28, 2025. https:\/\/accesspharmacy.mhmedical.com\/content.aspx?bookid=2569&sectionid=210259404"},{"issue":"9","key":"2026090211284261800_b13-0370265","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit Care Med"},{"issue":"2","key":"2026090211284261800_b14-0370265","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/CCM.0000000000000713","article-title":"Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients","volume":"43","author":"Lim","year":"2015","journal-title":"Crit Care Med"},{"issue":"3","key":"2026090211284261800_b15-0370265","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/87551225251328255","article-title":"Prophylactic enoxaparin dosing and anti-Xa levels in medicine patients with obesity","volume":"41","author":"Phyo","year":"2025","journal-title":"J Pharm Technol"},{"issue":"3","key":"2026090211284261800_b16-0370265","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.thromres.2009.02.003","article-title":"Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-ill patients","volume":"125","author":"Rondina","year":"2010","journal-title":"Thromb Res"},{"issue":"4","key":"2026090211284261800_b17-0370265","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s11239-024-02951-w","article-title":"A systematic review of therapeutic enoxaparin dosing in obesity","volume":"57","author":"Chilbert","year":"2024","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"2026090211284261800_b18-0370265","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40261-019-00855-9","article-title":"Stratifying therapeutic enoxaparin dose in morbidly obese patients by BMI class: a retrospective cohort study","volume":"40","author":"Lee","year":"2020","journal-title":"Clin Drug Investig"},{"issue":"8","key":"2026090211284261800_b19-0370265","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1177\/1060028020974569","article-title":"Safety of high-dose unfractionated heparin for prophylaxis of venous thromboembolism in hospitalized obese patients","volume":"55","author":"Regis","year":"2021","journal-title":"Ann Pharmacother"},{"issue":"2","key":"2026090211284261800_b20-0370265","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11239-019-01942-6","article-title":"Intravenous unfractionated heparin dosing in obese patients using anti-Xa levels","volume":"49","author":"Ebied","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"2026090211284261800_b21-0370265","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11239-016-1466-9","article-title":"Evaluation of safety and effectiveness of standardized antifactor Xa-based unfractionated heparin protocols in obese versus non-obese patients","volume":"43","author":"Isherwood","year":"2017","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"2026090211284261800_b22-0370265","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s11096-020-01004-5","article-title":"Unfractionated heparin dosing in obese patients","volume":"42","author":"George","year":"2020","journal-title":"Int J Clin Pharm"},{"issue":"19","key":"2026090211284261800_b23-0370265","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"suppl 1","key":"2026090211284261800_b24-0370265","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1182\/blood-2024-202466","article-title":"Superior safety and efficacy of DOACs over warfarin in obese patients: a propensity-matched cohort study","volume":"144","author":"Akbar","year":"2024","journal-title":"Blood"},{"issue":"1","key":"2026090211284261800_b25-0370265","doi-asserted-by":"publisher","first-page":"e41596","DOI":"10.1016\/j.heliyon.2024.e41596","article-title":"Evaluating the efficacy and safety of direct oral anticoagulants compared to warfarin in very morbidly obese patients with non-valvular atrial fibrillation: a retrospective cohort study","volume":"11","author":"Ezaldin","year":"2025","journal-title":"Heliyon"},{"issue":"5","key":"2026090211284261800_b26-0370265","doi-asserted-by":"publisher","first-page":"e0171923","DOI":"10.1128\/aac.01719-23","article-title":"Updated antimicrobial dosing recommendations for obese patients","volume":"68","author":"Castro-Balado","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"2026090211284261800_b27-0370265","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/cid\/ciu027","article-title":"DALI: defining antibiotic levels in intensive care unit patients: are current \u03b2-lactam antibiotic doses sufficient for critically ill patients?","volume":"58","author":"Roberts","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2026090211284261800_b28-0370265","doi-asserted-by":"publisher","first-page":"227","DOI":"10.14740\/jocmr1858w","article-title":"Pharmacokinetic changes and dosing modification of aminoglycosides in critically ill obese patients: a literature review","volume":"6","author":"Velissaris","year":"2014","journal-title":"J Clin Med Res"}],"container-title":["AACN Advanced Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacnjournals.org\/aacnacconline\/article-pdf\/37\/3\/265\/172263\/265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacnjournals.org\/aacnacconline\/article-pdf\/37\/3\/265\/172263\/265.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:28:47Z","timestamp":1788362927000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacnjournals.org\/aacnacconline\/article\/37\/3\/265\/33149\/Finding-the-Right-Dose-Optimizing-Drug-Therapy-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9,15]]}},"URL":"https:\/\/doi.org\/10.4037\/aacnacc2026745","relation":{},"ISSN":["1559-7768","1559-7776"],"issn-type":[{"value":"1559-7768","type":"print"},{"value":"1559-7776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}